Enter the desired search word.
SEASUN THERAPEUTICS is developing new medicines for different types of diseases using ‘original technology POLIGO’ based on an artificial nucleic acid PNA.
SEASUN THERAPEUTICS will become a leading company in the
development of new biomedicines by using the original technology POLIGO.
SEASUN THERAPEUTICS CEO
Lim mi jung
Scientific Advisory Board (SAB)
TREATMENT DEVELOPMENT ADVISORY
Woo-Chan SON
· Professor of pathology at Asan Medical Center
· Previously at Huntingdon Life Sciences Senior Pathologist
History